Allicin amplifies disulfidptosis during GOx catalyzing glucose-starvation for cancer therapy via simultaneous antimicrobial and antitumor intervention
Chemical Engineering Journal · 2025-02 · 505 · 159871
DOI: 10.1016/j.cej.2025.159871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2025-02. Verfasst von Taotao Huo und 13 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shaanxi Province Natural Science Foundation, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Shaanxi Province Natural Science Foundation
- Fundamental Research Funds for the Central Universities
- Xi’an Jiaotong University
Zitieren
APA
Huo, T., Zhu, B., Shan, X., Song, J., Wang, Z., Zhou, J., Zhang, X., Bai, Y., Liu, C., Zhao, Y., Mei, N., Bu, Y., Zhang, J., & Li, G. (2025). Allicin amplifies disulfidptosis during GOx catalyzing glucose-starvation for cancer therapy via simultaneous antimicrobial and antitumor intervention. Chemical Engineering Journal, 505, 159871. https://doi.org/10.1016/j.cej.2025.159871
Vancouver
Huo T, Zhu B, Shan X, Song J, Wang Z, Zhou J, et al. Allicin amplifies disulfidptosis during GOx catalyzing glucose-starvation for cancer therapy via simultaneous antimicrobial and antitumor intervention. Chemical Engineering Journal. 2025;505:159871. doi:10.1016/j.cej.2025.159871
BibTeX
@article{Huo2025,
author = {Huo, Taotao and Zhu, Bin and Shan, Xiaoyu and Song, Jiaqi and Wang, Ziyi and Zhou, Jianxu and Zhang, Xianpeng and Bai, Yuquan and Liu, Chengcheng and Zhao, Yiyang and Mei, Na and Bu, Yazhong and Zhang, Jia and Li, Guangying},
title = {Allicin amplifies disulfidptosis during GOx catalyzing glucose-starvation for cancer therapy via simultaneous antimicrobial and antitumor intervention},
journal = {Chemical Engineering Journal},
year = {2025},
volume = {505},
pages = {159871},
doi = {10.1016/j.cej.2025.159871}
}
EUVIMED